PL386977A1 - Composition for the prolonged releasing of heparin and the application of the alginate hydroxypropyl cellulose gel for the prolonged releasing of heparin - Google Patents

Composition for the prolonged releasing of heparin and the application of the alginate hydroxypropyl cellulose gel for the prolonged releasing of heparin

Info

Publication number
PL386977A1
PL386977A1 PL386977A PL38697708A PL386977A1 PL 386977 A1 PL386977 A1 PL 386977A1 PL 386977 A PL386977 A PL 386977A PL 38697708 A PL38697708 A PL 38697708A PL 386977 A1 PL386977 A1 PL 386977A1
Authority
PL
Poland
Prior art keywords
heparin
prolonged releasing
prolonged
releasing
composition
Prior art date
Application number
PL386977A
Other languages
Polish (pl)
Other versions
PL226261B1 (en
Inventor
Anna Karewicz
Katarzyna Zasada
Krzysztof Szczubiałka
Maria Nowakowska
Original Assignee
Uniwersytet Jagiellońskiuniwersytet Jagielloński
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Jagiellońskiuniwersytet Jagielloński filed Critical Uniwersytet Jagiellońskiuniwersytet Jagielloński
Priority to PL386977A priority Critical patent/PL226261B1/en
Priority to PCT/PL2009/000110 priority patent/WO2010077156A1/en
Priority to EP09809005A priority patent/EP2381962A1/en
Publication of PL386977A1 publication Critical patent/PL386977A1/en
Publication of PL226261B1 publication Critical patent/PL226261B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL386977A 2008-12-31 2008-12-31 Composition for the prolonged releasing of heparin and the application of the alginate hydroxypropyl cellulose gel for the prolonged releasing of heparin PL226261B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PL386977A PL226261B1 (en) 2008-12-31 2008-12-31 Composition for the prolonged releasing of heparin and the application of the alginate hydroxypropyl cellulose gel for the prolonged releasing of heparin
PCT/PL2009/000110 WO2010077156A1 (en) 2008-12-31 2009-12-22 Composition for prolonged release of heparin and use of the alginate-hydroxypropylcellulose gel for prolonged release of heparin
EP09809005A EP2381962A1 (en) 2008-12-31 2009-12-22 Composition for prolonged release of heparin and use of the alginate-hydroxypropylcellulose gel for prolonged release of heparin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL386977A PL226261B1 (en) 2008-12-31 2008-12-31 Composition for the prolonged releasing of heparin and the application of the alginate hydroxypropyl cellulose gel for the prolonged releasing of heparin

Publications (2)

Publication Number Publication Date
PL386977A1 true PL386977A1 (en) 2010-07-05
PL226261B1 PL226261B1 (en) 2017-07-31

Family

ID=42115718

Family Applications (1)

Application Number Title Priority Date Filing Date
PL386977A PL226261B1 (en) 2008-12-31 2008-12-31 Composition for the prolonged releasing of heparin and the application of the alginate hydroxypropyl cellulose gel for the prolonged releasing of heparin

Country Status (3)

Country Link
EP (1) EP2381962A1 (en)
PL (1) PL226261B1 (en)
WO (1) WO2010077156A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109381448A (en) * 2017-08-04 2019-02-26 广州朗圣药业有限公司 A kind of razaxaban oral quick-dissolving film preparation and preparation method thereof
EP3813789A1 (en) 2018-06-28 2021-05-05 Arx, LLC Dispensing method for producing dissolvable unit dose film constructs

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4792452A (en) * 1987-07-28 1988-12-20 E. R. Squibb & Sons, Inc. Controlled release formulation
US5695781A (en) * 1995-03-01 1997-12-09 Hallmark Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers
US5811126A (en) * 1995-10-02 1998-09-22 Euro-Celtique, S.A. Controlled release matrix for pharmaceuticals
WO2001037802A1 (en) * 1999-11-29 2001-05-31 Advanced Research And Technology Institute, Inc. Sustained percutaneous delivery of a biologically active substance
KR100548925B1 (en) * 2002-10-23 2006-02-02 한미약품 주식회사 Sustained release composition for oral administration of a drug
US7704977B2 (en) * 2006-04-07 2010-04-27 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
WO2009079537A1 (en) * 2007-12-17 2009-06-25 New World Pharmaceuticals, Llc Sustained release of nutrients in vivo

Also Published As

Publication number Publication date
WO2010077156A1 (en) 2010-07-08
PL226261B1 (en) 2017-07-31
EP2381962A1 (en) 2011-11-02

Similar Documents

Publication Publication Date Title
HK1256805A1 (en) Pharmaceutical composition and administrations thereof
ZA201003761B (en) Polysaccharide gel formulation
EP2139596A4 (en) Preparation of polysaccharide beads
IL238395B (en) Soluble human serum attachment components, compositions, and methods of production thereof
EP2327750A4 (en) Adhesive composition and adhesive agent comprising same
PL2046405T3 (en) Biomaterials, their preparation and use
EP2271657A4 (en) Gel microdrop composition and method of using the same
PT2011816T (en) Co-reticulated polysaccharide gel
EP2174985A4 (en) Gel composition and cosmetic preparation
EP2358301A4 (en) Regenerative tissue grafts and methods of making same
ZA201008379B (en) Glucocorticoid mimetics,methods of making them,pharmaceutical compositions,and uses thereof
EP2166874A4 (en) Microencapsulating compositions, methods of making, methods of using and products thereof
ZA201003290B (en) Keratin derivatives and methods of making the same
EP2247623A4 (en) New cellulose derivatives, method of producing the same and use thereof
IL206594A (en) Azinone-tetrahydropyridoindole derivatives and pharmaceutical compositions comprising thereof
EP2236522A4 (en) Cellulose derivative and hydrogel thereof
IL206562A0 (en) Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition
EP2340297A4 (en) Composition, method of making the same, and use thereof
EP2338917A4 (en) Sulfated derivative of gastrodia elata polysaccharide, preparation method and use thereof
PL2344489T3 (en) Process for the preparation of vinpocetine and apovincamine
EP2361907A4 (en) The five crystal forms of the nicousamide, the preparation methods, the pharmaceutical compositions and the uses thereof
HK1168793A1 (en) Glucose metabolism-improving agent and glucose metabolism-improving composition
PL386977A1 (en) Composition for the prolonged releasing of heparin and the application of the alginate hydroxypropyl cellulose gel for the prolonged releasing of heparin
PL2288744T3 (en) Combination of chitosan film and hydrogel, and surgical uses thereof
EP2301532A4 (en) Use of statins as anticonvulsants, antiepileptics and neuroprotectors